Checking Formularies and Coverage It's essential to review the formulary of your specific Medicare Part D plan to gain clarity on coverage for GLP-1 agonist drugs
The approval of this new class of weight loss medications advances the case towards treating obesity as a disease, but these medications are meant to be used alongside lifestyle changes such as nutrition and exercise
Thus, utilizing options like manufacturer savings cards for diabetes patients with commercial insurance can help manage expenses
Key Takeaways GLP-1 injection site reactions can include redness, itching, rash, bruising, swelling, pain, lumps, or thicker skin
Exenatide was approved by the US FDA in 2005 and by the European Medicines Agency (EMA) in 2006